MATERIALS AND METHODS
We have studied the efficacy of therapy with
ovaries peptides («Zhenoluten») and pineal
gland peptides («Endoluten») in 214 patients
aged 34 to 38 years old with a moderate
decrease in reproductive function. The study
did not include patients with:
• unstable menstruation,
• chronic adnexitis,
• polycystic ovarian disease, The study of the effectiveness of the
• endometriosis, complex of peptide medications was
• tubal obstruction, carried out from September 2013 to
• uterine myoma, June 2018 at the Moscow office of the
• autoimmune thyroiditis, Peptides Center of Revitalization and
• pituitary microadenoma, Health. All patients were examined
• a slight or moderate increase in the level of before the start of the therapy, as
prolactin, indicating the possible presence well as after 2 and 4 months from the
of the so-called hypothalamic syndrome. beginning of the use of peptides of theIn the latter case, the use of pineal gland pineal gland and ovaries.drugs may shorten or lengthen the menstrual
All peptide preparations participatingcycle and increase hypophysis stimulation,
in the study were developed by the St.which is most often expressed in an increase
Petersburg Institute of Bioregulationin the level of follicle-stimulating hormone
(FSH) and less often in fluctuations in the and Gerontology and are, in essence,
level of luteinizing hormone (LH). parapharmaceutical complexes of
low-molecular-weight peptides with
a molecular weight of up to 5000 Da,
produced from organs and tissues
of young animals – calves up to 12
months of age.
100 // Health territory. PEPTIDES. The Reproductive System
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.